Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Definitely before the misleading yearly repeat of going out of business before years end.
CANB- 2021....And Beyond
Misleading...CANB Headed to $1.00 Plus Easily, mark it. After over 100% run in a month,BabyLow Volume pullbacks if any was expected.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No Wonder CANB Chart is fast Approaching it’s Yearly High so quickly, Smart Money has done its DD and Continues to Accumulate.
CANB-2021- and Beyond.
CANB Up almost 10% Today. So much for misleading information.
Smart Money Continues to Accumulate....
Dollar Land Plus Fast Approaches.
Excellent News Release for CANB! Love the 10 Million Dollar Wholesale Value it could bring.
:
Marco Alfonsi, Can B's Chief Executive Officer, commented, "This is a major milestone for our Company as we have completed our previously announced hemp isomer pipeline fulfillment. It's an extremely attractive deal for us, especially from a cash flow perspective, as we were able to acquire the biomass in a restricted stock transaction valued at a $0.50 per pound basis. We then have a revenue split with the seller that will be calculated based on 70% of the post-processed value to the seller. At today's market price, one million pounds of hemp biomass, that when full processed into Delta 8 isomer has a wholesale value of approximately $10 million."
Correct, CANB almost 50k in Buys so far again today, setting up nicely for Dollar Land Plus.
Goes to show, not so easy to Fool Smart Money from Accumulating at these Oversold Levels.
CANB 5%/25K Up on the open. Goes to show, Just can’t fool Smart Money so easily into selling.
Accumulation Continues 2021....And Beyond.... Period.
Yet All Eyes Continue to Watch 24/7......hmmm
CANB 2021- and Beyond
CANB Up almost 4% on 40K. Best not to keep hoping for a lower price as Dollar Land Fast Approaches, Mark It.
Misleading, 1.5% baby pullbacks on low volume is normal, especially after a month with over 100% gain., stocks 101.
CANB..2021 and Beyond.
Misleading, 8% down on 20k....Yawn.
All Eyes remaining focused, CANB 2021 and Beyond.
Yep, CANB looking better then Ever. 2021 and Beyond will be Huge.
CANB 3% Up today Again. So much for the misleading bad week misinformation.
Agree, CANB chart shaping up for next Leg Up.
:
Nice head and shoulder pattern. Low volume red days followed by high volume green days.
CANB has consolidated beautifully
NASDAQ
CANB Up 10% on almost 80k Volume, looks like another good week coming.
Misleading baby pullbacks on low volume is normal, especially after a month with over 100% gain., stocks 101.
Misleading...CANB Headed to $1.00 Plus Easily, mark it. After over 100% run in a month,BabyLow Volume pullbacks if any was expected.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No Wonder CANB Chart is fast Approaching it’s Yearly High so quickly, Smart Money has done its DD and Continues to Accumulate.
CANB-2021- and Beyond.
Misleading...CANB Headed to $1.00 Plus Easily, mark it. After over 100% run in a month,BabyLow Volume pullback was expected. Would you look at that almost 5% Up today, this is only the Beginning.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No Wonder CANB Chart is fast Approaching it’s Yearly High so quickly, Smart Money has done its DD and Continues to Accumulate.
CANB-2021- and Beyond.
Add to that Good News;
Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
CANB $$$$
Correct, that’s why Accumulation Continues....$1.00 Plus Coming Soon.
:
Love the way CANB is playing out. A company that is completely integrated. Seed to sale.
HUGE profits
NASDAQ
CANB
The Badguy
Misleading, marked years end opinion 3 years ago...CANB still around this time only Better.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No Wonder CANB Chart is fast Approaching it’s Yearly High so quickly, Smart Money has done its DD and Continues to Accumulate.
CANB-2021- and Beyond.
Excellent News Release, CANB Continues to Impress with more Expansion. Love this Part:
Marco Alfonsi, Can B's Chief Executive Officer, commented, 'Securing this lease to be able operate from this facility is a huge win for our Company. Its location, footprint, and existing infrastructure will accelerate our capabilities and enable us to become among the leading producers of hemp-based cannabinoid products in America.'
Misleading, marked years end opinion 3 years ago...CANB still around this time only Better.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No Wonder CANB Chart is fast Approaching it’s Yearly High so quickly, Smart Money has done its DD and Continues to Accumulate.
CANB-2021- and Beyond.
Misleading, marked years end opinion 3 years ago...CANB still around this time only Better.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No Wonder CANB Chart is fast Approaching it’s Yearly High so quickly, Smart Money has done its DD and Continues to Accumulate....Period.
Looks Like CANB Investors are Loading today Again. Last I checked up 5% so far.
Dollar Land Plus Fast Approaches.
Congrats to the Many CANB Investors who purchased around the .40 range last month and are Up 100% And Climbing.
Proves its best to follow the DD like Smart Money is doing.
Dollar Land Plus Fast Approaches :)
Correct, Smart Money Loading Every Day. Type O today stating 8% down. Looks like 2.4% real numbers.
Healthy Minor correction on low volume before next leg up to Dollar Land Plus.
Accumulation Continues.
Very Smart Indeed.
Misleading, 2-3% healthy pullback is normal after a 100% Gain inside a month. opinion on lucky to be around by years end has been mentioned 3 years ago.
Now the Facts: Honest DD done by Investors clearly shows CANB
*Continues to Grow and Expand.
*Eliminate Debt
*New Products
*Continued Profit Growth
Dollar Land Plus Fast Approaching $$$$
Mark It $$$$$$
No wonder Growth and Expansion Continue for CANB. Love this Part:
This acquisition, along with the previously announced TWS Pharma acquisition, will make CAN B a contender to become among the leading producers of hemp-based cannabinoid products in America. The addition of Music City Botanicals assets adds additional volume in extraction, isomer lab production, and R&D into the evolving isomer market with such products a Delta-10, CBG, CBN, and CBDA. New retail products will include pharmaceutical-grade CBD and related manufactured goods. In-house labeling and packaging now available to the Company will create a chain of custody and compliance process that is uncommon in the industry.
Another Great News Release from CANB Today, Impressive!
96% Revenue Growth for the 2nd Quarter!Excellent CANB News Just Released!
No Sonder The Growing Interest Daily/24/7!
:
Can B Corp. Reports 96% Revenue Growth for Its Second Quarter 2021
HICKSVILLE, NY / ACCESSWIRE / August 18, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing and selling hemp derived cannabinoid products, today announced the Company's financial results for the second quarter ended June 30, 2021 ("Q2 2021").
Key Financial and Business Highlights during and subsequent to Q2 2021
Revenue increased 96% over Q2 2020 to $0.4 million for Q2 2021
Adjusted EBITDA loss of $2.1 million (for the 1st half of 2021)
Partnered with group of professional Hollywood stuntmen and world champion action sports athletes for CBD products
Purchased additional equipment to increase production at its hemp facility in Colorado
Management Commentary ??Marco Alfonsi, Can B's Chief Executive Officer, stated, "We witnessed a nice uptick in business during the quarter as elective surgeries resumed and our medical durable equipment segment benefitted. Our business pipeline remains strong for both our own branded lines and our private label contract manufacturing. Additionally, our high activity of strategic corporate discussions and negotiations have led to meaningful opportunities such as the TWS Pharma asset acquisition announced via an 8K filing on August 17, 2021, adding over $5 million in assets to our balance sheet. Opportunities like these we believe will accelerate our growth and further solidify our balance sheet."
Financial Results for the Three Months Ended June 30, 2021:
Revenue: For the three months ended June 30, 2021, revenue was $0.4 million, an increase of $0.2 million, or 96%, compared with $0.2 million for the three months ended June 30, 2020. This increase was primarily due to the resumption of elective surgeries in 2021 which were temporarily paused through Q2 of 2020 due to the impact of the Covid-19 outbreak. Medical durable equipment utilized in elective surgeries is the Company's primary medical device revenue. In addition, the increase was related to operations of the Company's delta-8 synthesizing business which began in March 2021.
Gross Profit: For the three months ended June 30, 2021, gross profit was $0.1 million, a decrease of $0.1 million, or 9%, compared with $0.2 million for the three months ended June 30, 2020. The resulting gross margin was 35.6%, compared with 76.6% for the same quarter last year. The decrease in gross margin is due to an increase in medical durable equipment contribution to revenue and an increase in inventory pricing.
Total Operating Expenses: For the three months ended June 30, 2021, total operating expenses were $2.7 million, an increase of $1.5 million, or 115%, compared with $1.3 million for the same quarter last year. The increase in operating expenses was primarily due to professional fees incurred and attributable to the Company's asset acquisitions and Regulation A offering.
Operating Loss: For the three months ended June 30, 2021, operating loss was $0.6 million, an improvement of $0.2 million, compared with an operating loss of $0.8 million for the same quarter last year.
Net Loss: For the three months ended June 30, 2021, net loss was $2.8 million, or ($0.12) per share, compared with a net loss of $1.2 million, or a net loss of ($0.33) per share, for the three months ended June 30, 2020.
Cash: Cash and cash equivalents totaled $1.1 million as of June 30, 2021.
Financial Results for the Six Months Ended June 30, 2021:
Revenue: For the six months ended June 30, 2021, revenue was $0.7 million, a decrease of $0.1 million, or 9%, compared with $0.8 million for the same period last year. The Company began to rebound and increase revenues compared to prior periods in Q2 of 2021 due to the resumption and surge of elective surgeries in Q2 2021. In addition, certain distributors lost clients due to business closings which had an additional impact on the Company's overall revenue activity.
Gross Profit: For the six months ended June 30, 2021, gross profit was $0.4 million, a decrease of $0.2 million, or 38%, compared with $0.6 million for the same period last year. The resulting gross margin was 52.7%, compared with 78.1% for the same period last year.
Total Operating Expenses: For the six months ended June 30, 2021, total operating expenses were $4.8 million, an increase of $1.9 million, compared with $2.8 million for the same period last year.
Of note, $2.8 million of the Company's operating expenses for the six months ended June 30, 2021, were non-cash expenses, including depreciation, amortization, and stock-based compensation.
Operating Loss: For the six months ended June 30, 2021, operating loss was $4.4 million, an increase of $2.2 million, compared with an operating loss of $2.2 million for the same period last year.
Net Loss: For the six months ended June 30, 2021, net loss was $4.9 million, or ($0.26) per share, compared with $2.4 million, or ($0.65) per share, for the same period last year.
The Company filed its Form 10-Q on August 16, 2021, which can be viewed at https://www.otcmarkets.com/filing/conv_pdf?id=15167899&guid=DQM1kK7YUFBbNyh
About Can B Corp. ??Can B Corp. (OTCQB:CANB) is a health & wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. also operates R&D and production facilities in Lacey, WA and Florida. To learn more about Can B Corp. and our comprehensive line of high quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp ??Instagram @canbcorp ??Facebook @ Can B Corp ??YouTube
Which year end? That’s been said 3 years ago.
CANB looking Stronger then ever, Next Stop Dollar Land Plus , charts don’t lie.
Just Released, Another Great Article, here’s the section on CANB!
:
Four Cannabis Companies Capitalizing On Increased CBD Demand
CBD products are becoming popular among people of all ages. Here are four stocks to consider.??
OTCStockReview.com News Commentary??
ATLANTA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cannabis sales are on the rise this year as revenue and profits for many cannabis companies have increased significantly. U.S. legal cannabis sales grew 46% year over year to $17 billion in 2020. The total U.S. economic impact from marijuana sales in 2021 is expected to reach $92 billion – up more than 30% from last year – and upwards of $160 billion in 2025, according to analysis from the MJBizFactbook.
One of the major areas of interest to investors is Cannabidiol, or CBD, which is a component of marijuana that provides users with numerous health benefits without the high of regular marijuana. CBD has proven successful at reducing anxiety, combatting insomnia, and treating chronic pain. Since the 2018 Farm Bill legalized the growth and sale of CBD and Hemp, its popularity has skyrocketed. As marijuana becomes legal in more parts of the United States and North America, oils, creams, moisturizers, chews, isolate, gel caps, concentrate and spa products are just some of the new CBD products that are appearing nationwide. According to a 2019 survey conducted by Consumer Reports 20% of people ages 18-29 use CBD, 16% of people ages 30-49 use CBD, 11% of people ages 50-64 use CBD, and 8% of people age 65 and older use CBD.
e Can B Corp. (OTCQB: CANB) is a Health & Wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed, as well as licensing of durable medical devices. Can B sets itself apart from other companies by owning the production of its products from end to end. The Company owns Green Grow Farms Inc. which holds licenses to grow and cultivate CBD hemp as well as an extraction and processing registration in the State of New York.
Can B has an R&D laboratory located in its Pure Health Products production facility in Lacey WA. In this facility, Can B creates, develops, tests and produces all of its CBD products, under the highest industry standards which are also 3rd party independent lab tested with the Certificates of Analysis posted on the company’s website. Through its Duramed Division, Can B offers a line of FDA approved medical devices including an ultrasound delivery device which is proven to alleviate joint and muscle pain in surgery and accident patients, aid in recovery time, and reducswelling. These devices are sold and issued via doctors and the medical community and the company believes these devices are contributing to the reduction in opioid use.
On August 17, 2021 Can B announced it acquired three commercial buildings in Colorado valued at over $5 million for the processing of hemp biomass to CBD consumer products. This gives Can B total supply chain control and chain-of custody for purity, analysis, and certification of its products. The transaction is valued at over $5 million and will feed the Company's Nutraceutical lab in Lacey, Washington, as well as its two isomer (Delta-8- CBD- CBG) operations in Miami, Florida and McMinnville, Tennessee.
The acquisition consists of a 15,000 square foot facility located in Mead, Colorado that converts hemp biomass and unwinterized crude to winterized crude and high-quality CBD crude oil; an 18,000 square foot operation in Fort Morgan, Colorado, which is a former Budweiser facility, that will be used to convert winterized crude to CBD distillate; and an ICS facility located in a 30,000 sq. ft. building in Fort Morgan, CO that will be used to convert distillate to isolate. According to its press release, the Company has yet to execute the leases for these facilities but has negotiated and agreed on the terms with each landlord. For more information on Can B Corp. visit www.canbcorp.com.
Wrong stock, CANB up over 100% in a month. Chart showing its Next stop, yearly high,
Dollar Land Plus Coming, like Clock Work as predicted :)
Smart Money will not be tricked so easily into selling these Golden Shares.
CANB 2021 and Beyond.
Actually it is a Good Solid Acquisition by CANB. Love these Parts:
The transaction is valued at over $5 million for hemp processing and extraction assets located in 3 buildings totaling 50,000 square feet in northeast CO.
Marco Alfonsi, Can B's Chief Executive Officer, commented, "This is a significant move for our Company that we strongly believe will add value for our shareholders. It enables us to process biomass into isolate which is the core ingredient for hemp isomers, such as CBN, CBG, Delta-8 and Delta-10. It is strategic to our existing Lacey, Washington facility and expected to add significantly to revenue from now through the end of 2021. By securing our own processing and extraction facilities we for the first time control our supply chain from biomass through end products for both retail and wholesale customers".
The 15,000 square foot facility located in Mead, Colorado is a state-of-the-art extraction operation which converts hemp biomass and unwinterized crude to winterized crude and high-quality CBD crude oil. The 18,000 square foot operation in Fort Morgan, Colorado, a former Budweiser facility, will be used to convert winterized crude to CBD distillate. The ICS facility located in a 30,000 sq. ft. building also located in Fort Morgan CO and will be used to convert distillate to isolate. The Company has yet to execute the leases for these facilities but has negotiated and agreed on the terms with each landlord. This processing of hemp biomass to CBD consumer products gives us supply chain control and chain-of custody for purity, analysis, and certification of our products. The startup costs to have all the equipment fully functional and in full operation will require approximately $250,000 and 30 days.
All of these newly acquired assets will feed the Company's Nutraceutical lab in Lacey, Washington facility and the two isomer (Delta-8- CBD- CBG) operations in Miami Florida and Mcminville Tennessee. No Delta-8 will be produced in CO where it is illegal to do so.
In regard to biomass, the Company is in final negotiations to acquire several million pounds of biomass that is already harvested, bagged and partially dried. Historically, a million pounds of biomass converts to approximately 16,000 kilos of isolate that when fully processed to an isomer, converts into approximately 15,000 liters of Delta-8 or other isomers. At today's isomer market price this equates to a $10 million top line revenue per million pounds of biomass. At start-up production levels the existing CO operation is targeting an annual throughput of 1.5 million pounds of biomass processed.
Dave Stock, TWS Pharma majority owner, stated, "After weeks of detailed due diligence and planning, I believe Can B has a solid plan to utilize and monetize these assets. Coupled with their existing facility in Lacey, Washington gives them a feedstock to supplier to processor model that will allow them to compete at substantial volume of quality product at competitive pricing. Additionally, this transaction will award the local communities by welcoming back up to 30 returning local employees."
Next leg up on the yearly chart, $1.30. Monthly Gain over 100%....so far.
Excellent Acquisition by CANB. No wonder Expansion and Growth Continue.
:
CANB Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
https://www.accesswire.com/660022/can-b-corp-closes-acquisition-of-assets-from-tws-pharma-in-co-to-significantly-expand-capabilities-in-converting-hemp-biomass-to-isolate-used-in-our-cbd-and-isomer-product-lines
Adds $5 Million in Processing Assets
HICKSVILLE, NY / ACCESSWIRE / August 17, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company specializing in the development, production and sale of products containing hemp derived cannabinoids, is pleased to announce its acquisition of assets from TWS Pharma, based in Mead, Colorado.
The transaction is valued at over $5 million for hemp processing and extraction assets located in 3 buildings totaling 50,000 square feet in northeast CO.
Marco Alfonsi, Can B's Chief Executive Officer, commented, "This is a significant move for our Company that we strongly believe will add value for our shareholders. It enables us to process biomass into isolate which is the core ingredient for hemp isomers, such as CBN, CBG, Delta-8 and Delta-10. It is strategic to our existing Lacey, Washington facility and expected to add significantly to revenue from now through the end of 2021. By securing our own processing and extraction facilities we for the first time control our supply chain from biomass through end products for both retail and wholesale customers".
The 15,000 square foot facility located in Mead, Colorado is a state-of-the-art extraction operation which converts hemp biomass and unwinterized crude to winterized crude and high-quality CBD crude oil. The 18,000 square foot operation in Fort Morgan, Colorado, a former Budweiser facility, will be used to convert winterized crude to CBD distillate. The ICS facility located in a 30,000 sq. ft. building also located in Fort Morgan CO and will be used to convert distillate to isolate. The Company has yet to execute the leases for these facilities but has negotiated and agreed on the terms with each landlord. This processing of hemp biomass to CBD consumer products gives us supply chain control and chain-of custody for purity, analysis, and certification of our products. The startup costs to have all the equipment fully functional and in full operation will require approximately $250,000 and 30 days.
All of these newly acquired assets will feed the Company's Nutraceutical lab in Lacey, Washington facility and the two isomer (Delta-8- CBD- CBG) operations in Miami Florida and Mcminville Tennessee. No Delta-8 will be produced in CO where it is illegal to do so.
In regard to biomass, the Company is in final negotiations to acquire several million pounds of biomass that is already harvested, bagged and partially dried. Historically, a million pounds of biomass converts to approximately 16,000 kilos of isolate that when fully processed to an isomer, converts into approximately 15,000 liters of Delta-8 or other isomers. At today's isomer market price this equates to a $10 million top line revenue per million pounds of biomass. At start-up production levels the existing CO operation is targeting an annual throughput of 1.5 million pounds of biomass processed.
Dave Stock, TWS Pharma majority owner, stated, "After weeks of detailed due diligence and planning, I believe Can B has a solid plan to utilize and monetize these assets. Coupled with their existing facility in Lacey, Washington gives them a feedstock to supplier to processor model that will allow them to compete at substantial volume of quality product at competitive pricing. Additionally, this transaction will award the local communities by welcoming back up to 30 returning local employees."
Almost as funny as the .35 fiasco!
1.00 Plus next Leg.
:
Complete nonsense. I'm amazed how some foolishly believe stocks ONLY go up, up and up every day, day after day.
No people, stocks do have healthy consolidation days. Stock dynamics 101
Oh the comedy! Smh
CANB
NASDAQ
But, but, but, CANB was at .41 a month ago. Stocks 101, consolidation is expected after a Healthy Run like the one CANB is experiencing now before the next leg up.
Dollar Plus $1.30 will be the next stop before $3.00 Plus.
Very Misleading, some huge dump, 66k shares traded mixed buying and selling and only 4% down.
Facts, minor consolidation before next leg up to its yearly high of $1.30, Stocks 101.
CANB is only getting Started 2021 and Beyond $$$$$$
Excellent News, CANB continues to impress. No wonder Smart Money keeps Accumulating.
Correct monster week coming follows by monster month after month as CANB Gains Power.
Charts don’t lie, and this Chart screams.......Break Out.
$$$$$$$$$$$&